| |
| |
|
| Insider
Information: |
Mario Ernest |
| Relationship: |
Director |
| City: |
Redwood City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
1,151,697 |
|
|
Indirect Shares
|
265,510 |
|
|
| Direct
Value |
$8,420,214 |
|
|
|
Indirect Value
|
$116,216 |
|
|
| Total
Shares |
1,417,207 |
|
|
| Total
Value |
$8,536,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
2
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -41.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-03-07 |
4 |
OE |
$5.05 |
$8,893 |
D/D |
1,761 |
267,919 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-12-28 |
4 |
AS |
$4.52 |
$110,317 |
I/I |
(24,291) |
268,535 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-11-03 |
4 |
AS |
$13.30 |
$132,998 |
D/D |
(10,000) |
271,032 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-07-11 |
4 |
B |
$2.78 |
$99,999 |
D/D |
35,971 |
272,741 |
2.39 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2010-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
12,500 |
275,653 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-09-02 |
4 |
AS |
$12.60 |
$125,992 |
D/D |
(10,000) |
277,855 |
0 |
- |
|
| EYEN |
Eyenovia Inc |
Director |
– • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
280,779 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
281,032 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-08-01 |
4 |
AS |
$12.58 |
$125,817 |
D/D |
(10,000) |
287,855 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-03-15 |
4 |
B |
$5.13 |
$102,628 |
D/D |
20,000 |
287,919 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-12-27 |
4 |
AS |
$4.65 |
$354,050 |
I/I |
(75,709) |
292,826 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-03-16 |
4 |
B |
$4.78 |
$23,898 |
D/D |
5,000 |
292,919 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-04-04 |
4 |
OE |
$5.05 |
$8,888 |
D/D |
1,760 |
294,679 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2005-07-20 |
4 |
S |
$58.55 |
$1,469,330 |
D/D |
(25,000) |
295,015 |
|
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2016-05-10 |
4 |
B |
$4.76 |
$3,804 |
D/D |
800 |
297,240 |
2.31 |
- |
|
| PPDI |
Pharmaceutical Product De... |
officerTitle |
– • – |
2005-12-22 |
4 |
OE |
$9.75 |
$24,375 |
D/D |
2,500 |
297,515 |
|
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-07-01 |
4 |
AS |
$12.95 |
$129,468 |
D/D |
(10,000) |
297,855 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
officerTitle |
– • – |
2006-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,032 |
298,547 |
|
- |
|
| BSX |
Boston Scientific Corp |
Director |
– • – |
2011-11-21 |
4 |
B |
$5.30 |
$132,500 |
D/D |
25,000 |
306,004 |
2.39 |
- |
|
| BSX |
Boston Scientific Corp |
Director |
• • – |
2014-06-02 |
4 |
AS |
$12.88 |
$128,790 |
D/D |
(10,000) |
307,855 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2011-03-14 |
4 |
A |
$0.00 |
$0 |
I/I |
32,916 |
308,569 |
0 |
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2004-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
312,426 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2004-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
800 |
313,426 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2004-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,000 |
314,226 |
|
- |
|
| PPDI |
Pharmaceutical Product De... |
Director |
– • – |
2004-12-21 |
4 |
OE |
$9.75 |
$29,250 |
D/D |
3,000 |
315,426 |
|
- |
|
373 Records found
|
|
Page 11 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
